Who is sponsoring NCT05416255?

NCT05416255 is sponsored by Dharma Bioscience.

What drugs are being tested in NCT05416255?

Interventions in NCT05416255: Measuring synovial fluid components.

What condition does NCT05416255 study?

NCT05416255 studies Knee Osteoarthritis.

Is NCT05416255 still recruiting?

NCT05416255 is currently status unknown. Last updated 30 April 2024.

Last reviewed 2024-04-30 · How we verify

NCT05416255

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measuring Synovial Fluid Components

Status unknown NA Last updated 30 April 2024

What this trial tests

NA trial testing Measuring synovial fluid components in Knee Osteoarthritis in 80 participants. Status unknown.

Timeline

1 April 2022

Primary endpoint
31 August 2024

31 December 2024

Quick facts

Lead sponsor	Dharma Bioscience
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	1 April 2022
Primary completion	31 August 2024
Estimated completion	31 December 2024
Sites	1 location across Argentina

Drugs / interventions tested

Measuring synovial fluid components

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Dharma Bioscience

Who can join

Adults 18 to 80, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants with grade 3 and 4 knee osteoarthritis will recieve aspiration of synoivial fluid, and then receive either dextrose, hemaotopoietic stem cell, or platelet rich plasma, or no injection. The synovial fluid will be analyzed for changes in components.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05416255 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dharma Bioscience
Last refreshed: 30 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05416255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing